ArticleJournal of hematology & oncology2017
Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas.
Audrey Laroche et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it